EP0837063A1 — 4-Aminoquinazoline derivatives
Assigned to Pfizer Inc · Expires 1998-04-22 · 28y expired
What this patent protects
This invention relates to certain 4-aminoquinazoline derivatives of the formula and their pharmaceutically acceptable salts wherein R 1, Q 1 , m, n, and Z are defined as in the specification. The compounds of formula I and pharmaceutically acceptable salts are useful for the t…
USPTO Abstract
This invention relates to certain 4-aminoquinazoline derivatives of the formula and their pharmaceutically acceptable salts wherein R 1, Q 1 , m, n, and Z are defined as in the specification. The compounds of formula I and pharmaceutically acceptable salts are useful for the treatment of hyperproliferative disorders and conditions in mammals.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.